WHO: New coronary pneumonia mortality rate estimated to be 10 times higher than influenza

Home Health WHO: New coronary pneumonia mortality rate estimated to be 10 times higher than influenza

Original title: WHO: New coronary pneumonia mortality rate is estimated to be 10 times higher than influenza

Xinhua News Agency, Geneva, April 9 (Reporter Liu Qu) The World Health Organization said on the 9th that the new coronary pneumonia mortality rate is estimated to be 10 times higher than influenza.

At the epidemic briefing, WHO Director General Tan Desai said that since the organization launched the first new coronary pneumonia strategic preparation and response plan two months ago, the situation has changed a lot. The global spread of the new coronavirus has overwhelmed the health systems of many countries and disrupted the global economy.

He pointed out that the mortality rate of new coronary pneumonia is estimated to be 10 times higher than that of influenza. Although everyone has already witnessed the harm the new coronavirus has caused to developed countries, the possible damage it has caused in poorer and more vulnerable countries has not yet fully manifested. “We promise to do everything we can to prevent this from happening.”

Tan Desai said that the number of infected people in Africa is relatively small, but it is growing rapidly. As early as January, WHO announced that the new coronary pneumonia epidemic constitutes a public health emergency of international concern. The purpose is to allow countries and regions, especially those with weak health systems, to have time to prepare. But now it seems that the “opportunity window” at this time is closing in many countries.

The WHO also announced that the second new coronary pneumonia strategic preparation and response plan will be released in the next few days. The new plan will include the latest knowledge of the new corona virus and the lessons learned in the prevention and control process, the reduction of mortality through appropriate care, and the development of safe and effective vaccines and therapies.

“On this (anti-epidemic) road, we still have a long way to go,” Tan Desai said. “We must ‘segregate’ the politicization of the epidemic at the national and global levels. We We must work together, we have no time to waste. ”

  

Editor in charge: Zhang Jianli